Navigation Links
Media Advisory - Oncolytics Biotech Inc. to Present at BioSquare 2008
Date:3/10/2008

CALGARY, March 10 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and CEO of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the BioSquare 2008 Conference on Thursday, March 13, 2008. The event is being held at the Congress Center in Basel, Switzerland from March 12-14, 2008.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com

The presentation times are subject to change. This release and the presentation related thereto contain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control and which may cause actual results, performance or achievements of the Company to be materially different from the results, performance or expectations implied by these forward-looking statements. Such risks and uncertainties include, among others, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, uncertainties related to the research and development of pharmaceuticals and uncertainties related to the regulatory process. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statemen
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
2. Mediatech Moves to Prince William County Innovation Park
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
6. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Scientists Using Social Media to Inform Lab Purchasing Decisions
11. NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Sept. 15, 2014 The chemistry, taste, and health ... a new article published by the nonprofit American Botanical Council ... climate change and its effects on the phytochemical compounds in ... study conducted by Dr. Ahmed in the Yunnan ... and has implications for the future of medicinal botanicals. Dr. ...
(Date:9/15/2014)... septembre 2014 La deuxième édition annuelle ... (semaine internationale sur la sensibilisation au plasma) sera ... de la Plasma Protein Therapeutics Association ... l,IPAW vise à : , Sensibiliser ... collecte du plasma-aphérèse , Reconnaître la contribution ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Hydro ... ) announced today that it will be partnering ... CA ( http://www.proteaf.com ) for implementing its Shock ... value continuous processing. Continuous flow chemistry through ... chemical, pharmaceutical and petrochemical markets for decades. ...
(Date:9/14/2014)... Bacteria are particularly ingenious when it comes to survival ... from a hostile environment, for example during treatment with ... surrounded by a protective slime capsule consisting of sugar ... Universiteit Brussel have for the first time created a ... curli building blocks cross the bacterial cell wall, a ...
Breaking Biology Technology:Tea Taste and Quality Affected by Climate Change 2Tea Taste and Quality Affected by Climate Change 3Tea Taste and Quality Affected by Climate Change 4L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 2L' International Plasma Awareness Week célébrera les donneurs et braquera les projecteurs sur les maladies rares 3Hydro Dynamics Partners with the Continuous Flow Chemistry Experts of Proteaf Technologies 2New insights in survival strategies of bacteria 2
... April 14 /PRNewswire-FirstCall/ - Neptune Technologies & Bioressources Inc. ... financial results of the fiscal 2009 third quarter and ... the year-end results for its fiscal year 2009 now ... for the three-month period ended February 28, 2009 in ...
... April 13, 2009 Applied scientists at the Harvard ... with researchers from Hamamatsu Photonics in Hamamatsu City, Japan, ... the direction of oscillation of the emitted radiation, known ... The innovation opens the door to a wide range ...
... Bedford Laboratories(TM), a division of Ben Venue Laboratories, Inc., ... mL in PVC flexible containers to its existing Fluconazole ... is equivalent to Diflucan(R) by Pfizer. Fluconazole injection ... candidiasis, cryptococcal meningitis, and is also indicated for the ...
Cached Biology Technology:Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 2Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 3Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 4Neptune Technologies to expect Record Revenues; Fiscal 2009 Third Quarter and Year-End Results 5Scientists demonstrate laser with controlled polarization 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
(Date:9/15/2014)... life it,s not what comes to mind when you ... of Doncaster,s 310-million-year-old past, including a fossilised shark egg case, ... of the fossilised plants and creatures may even be new ... horseshoe crabs and some previously unrecorded seed pods are amongst ... formed within the coal and shale deposits in what is ...
(Date:9/15/2014)... balance between ridding the body of a dangerous virus ... appearing in The Journal of Experimental Medicine ... chronic infections in roughly three-quarters of infected people, putting ... cirrhosis and cancer. A few patients successfully eliminate infection, ... T cells. The protective effects of CD8 + ...
(Date:9/15/2014)... Ore. Amid conflicting reports about the need for ... analysis published today suggests that adequate levels of this ... the elderly, and women who are or may become ... is also important, researchers said, but often complicated by ... most difficult to obtain through diet alone. It has ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3
... & IRRI (The International Rice Research Institute) today announced ... a new strategy that will galvanize agricultural research focused ... by a 2.55M USD grant to CAMBIA from The ... Initiative ?Biological Innovation for Open Society- is often called ...
... from researchers at Harvard Medical School and Massachusetts Institute ... Cancer Conference (ECCO) have shown for the first time ... , Nucleic acid ligands (referred to as aptamers) ... to target antigens with high specificity and affinity; analogous ...
... standard Internet protocol that checks errors made during ... to transform DNA microarray analysis, a common technology ... which blends experiment and computation, strengthens DNA microarray ... who is publishing his findings in the December ...
Cached Biology News:Open Source Biotechnology alliance for international agriculture 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 2Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 3Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates 4Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 2Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool 3
...
D.R. Harper (1993) • Includes: essential information on taxonomy, culture and safe handling of viruses, immunology, monoclonal antibodies, antivirals and vaccines....
... (1995) • This book is unique ... and molecular techniques currently used in ... analysis of virus-specific antibodies and clinical ... covering immunoassays, blotting and hybridization procedures, ...
Bovine Serum...
Biology Products: